Introduction
Antimicrobial resistance poses a serious security threat to global health. In Thailand alone, such resistance is estimated to have caused 38 000 deaths and an economic loss of 1.2 billion United States dollars (US$) in 2010. 1 Subsequent global attention and national concern pushed the Thai government to take action against antimicrobial resistance.
The increased prevalence and global spread of drugresistant microorganisms are alarming. 2 Antimicrobial resistance is recognized as a key security threat to global health. By 2050 -if effective interventions against antimicrobial resistance are not made -10 million deaths and an economic loss of US$ 100 trillion may occur annually as the result of such resistance. 3 In 2015, the Sixty-eighth World Health Assembly adopted a Global action plan for antimicrobial resistance and called on each Member State to develop and implement a corresponding context-specific national plan. 4 Discussion of antimicrobial resistance at the United Nations General Assembly in September 2016 led to a political declaration that endorsed the implementation of the global action plan using a One Health approach. 5, 6 Thailand has previously addressed antimicrobial resistance with fragmented approaches. For example, antimicrobial resistance formed a small component of the National drug development strategy (2012) (2013) (2014) (2015) (2016) and the National strategic plan on emerging infectious disease (2013) (2014) (2015) (2016) . Although several relevant working groups were established, no platform for coordination existed and only very limited policy guidance. None of the working groups established national indicators, systems for monitoring and evaluation or targets. Fragmentation and the lack of both coordination and concerted efforts hampered progress.
Local setting
In Thailand, although the widespread availability of antibiotics from private pharmacies leads to frequent self-medication in households, no systems exist either to monitor the human consumption of antibiotics or to assess the general public's knowledge and perceptions of -or attitudes towards -antibiotics and antimicrobial resistance. A national system for the surveillance of antimicrobial resistance in humans was initiated by the ministry of public health's department of medical sciences in 1998 7 but this system covered only 92 (9%) of the country's 1027 hospitals by 2017. Furthermore, the use of the antimicrobial resistance profiles and prevalence determined at these 92 sentinel hospitals to guide clinical decision-making by pharmacists or physicians appears to be uncommon.
Thailand's department of livestock development and food and drug administration have conducted some smallscale monitoring of antimicrobial resistance in livestock, and Problem In Thailand, antimicrobial resistance has formed a small component of national drug policies and strategies on emerging infectious diseases. However, poor coordination and a lack of national goals and monitoring and evaluation platforms have reduced the effectiveness of the corresponding national actions. Approach On the basis of local evidence and with the strong participation of relevant stakeholders, the first national strategic plan on antimicrobial resistance has been developed in Thailand. Local setting Before the development of the plan, ineffective coordination meant that antimicrobial resistance profiles produced at sentinel hospitals were not used effectively for clinical decision-making. There was no integrated system for the surveillance of antimicrobial resistance, no system for monitoring consumption of antimicrobial drugs by humans, livestock and pets and little public awareness of antimicrobial resistance. Relevant changes In August 2016, the Thai government endorsed a national strategic plan on antimicrobial resistance that comprised six strategic actions and five targets. A national steering committee guides the plan's implementation and a module to assess the prevalence of household antibiotic use and antimicrobial resistance awareness has been embedded into the biennial national health survey. A national system for the surveillance of antimicrobial consumption has also been initiated. Lessons learnt Strong political commitment, national ownership and adequate multisectoral institutional capacities will be essential for the effective implementation of the national plan. A robust monitoring and evaluation platform now contributes to evidence-based interventions. An integrated system for the surveillance of antimicrobial resistance still needs to be established.
Lessons from the field 
Approach
In Thailand, the development of a National strategic plan on antimicrobial resistance at the end of 2015 was perhaps the most important step towards addressing the fragmentation in the investigation of antimicrobial resistance and the lack of associated systematic interventions. The many stakeholders involved in this development included those working in the agriculture, animal health and human health sectors, civil society organizations, the Food and Agricultural Organization of the United Nations (FAO) and the World Health Organization (WHO). The implementation of the plan was facilitated by the creation of a national coordinating committee for antimicrobial resistance, which had the support of a cross-ministerial joint secretariat. The plan was based on both the relevant local evidence that was available -e.g. on antimicrobial resistance in hospitals, livestock and food products and on resistance-attributable mortality and economic losses -and on the relevant information available from other countries -e.g. on policies and practices that curb antimicrobial consumption and systems for the surveillance of antimicrobial resistance.
In December 2015, in response to the need for evidence-based policy formulation and multisectoral actions, antimicrobial resistance was included in the agenda of Thailand's eighth national health assembly. 10 Representatives from academia, civil society and government intensively reviewed the Draft national strategic plan on antimicrobial resistance and officially adopted a resolution on the collaborative and comprehensive management of antimicrobial resistance in Thailand. To ensure that the final plan was based on broad stakeholder involvement, the draft plan was discussed by several hundred stakeholders over three public hearings. At the first of these hearings, the members of the antimicrobial resistance coordinating committee introduced the proposed plan's key features. The plan was drafted in detail at the second hearing and finalized at the third hearing. Antimicrobial resistance is the focus of one of six programmes included in the Thai government's country cooperation strategy for 2017-2021.
Relevant changes
After a series of meticulous engagement processes -in particular for identifying potential problems and strategic directions -the Thai government finally endorsed the strategic plan in August 2016 (Box 1). A national steering committee, chaired by the deputy prime minister, is charged with overseeing and coordinating the plan's implementation and eliminating the fragmentation that hampered previous investigations of antimicrobial resistance in Thailand. It is hoped that the stakeholders' involvement in the plan's development will lead to a genuine sense of stakeholder ownership and the plan's long-term efficacy and sustainability. It is also hoped that the trust-based relationships that exist among the steering committee's longserving technocrats who facilitated the plan's development, i.e. government officials in the ministries of health and agriculture -will strengthen and then also support the plan's effective long-term implementation. However, it may be difficult to sustain policy commitment because of the typically high turnover of policy-makers.
The strategic plan is designed to act as a framework that assigns different responsibilities to different institutions and sectors -according to their mandates -with the ultimate aim of achieving set national goals and targets (Box 1).
To strengthen the monitoring and evaluation of antimicrobial resistance and develop the surveillance of antimicrobial consumption, the International Health Policy Program of Thailand's ministry of public health has convened a series of intensive consultations. These consultations cover multiple stakeholder groups: faculties of pharmacy and veterinary medicine, FAO, several hospitals, Thailand's department of livestock development, food and drug administration and national laboratory and WHO. The examination of key data sets on antimicrobial sales -i.e. the results of mandatory reporting by importers and manufacturers to the food and drug administration -indicates that it may be feasible to apply similar approaches in Thailand to those used in Europe by the European surveillance of antimicrobial consumption network 11 and the European surveillance of veterinary Lessons
antimicrobial consumption project. 12 An assessment of total antimicrobial consumption by humans, livestock and pets should provide useful data for monitoring the progress of the strategic plan's implementation. 13 The magnitude, pattern and types of antibiotic use in pets will be assessed because people commonly use antibiotics created for human consumption to treat their pets. Assessment of the wide use of antibiotics to treat greening diseases in citrus trees is also underway.
Adequate monitoring of the prevalence of antimicrobial resistance in Thailand will require both the existing system for monitoring humans to be strengthened and a whole new system for monitoring livestock and pets to be established. Ideally, given the emergence of resistant foodborne infections in humans, disease surveillance for humans and livestock needs to be integrated. 6, 14 A new module on antimicrobial resistance, based on a slight adaptation of the format used in the Euro-Barometer 445 survey of such resistance, 15 has been embedded into Thailand's biennial national health and welfare surveys, i.e. nationally representative household surveys conducted by the national statistical office. The International Health Policy Program's longterm institutional relationship with the national statistical office facilitated the inclusion of the new module. The module will be used to assess the prevalence of self-use of antibiotics, knowledge and awareness of antimicrobial resistance and sources of information on antimicrobial resistance. Ideally, all decision-making on antimicrobial use -by clinicians, policy-makers, the general public and veterinarians -needs to be evidence-based.
Lessons learnt
Strong political commitment, national ownership and increased institutional capacities contributed to the development of the strategic plan (Box 2).
Looking ahead, the plan's effective implementation will require the remaining challenges to be overcome, continued political commitments and a strong technical secretariat. The process of developing the strategic plan placed a high priority on engagement and ownership by key actors, particularly the technocrats who were involved in much of the plan's contents and who will, probably, be much involved in the plan's implementation. Given the high turnover of policy-makers, it may be difficult to sustain policy commitment. ■
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Резюме
Устойчивость возбудителей к противомикробным препаратам: от глобальной повестки дня до национального стратегического плана, Таиланд
Проблема В Таиланде проблема устойчивости возбудителей к противомикробным препаратам стала одним из второстепенных направлений национальной политики и стратегии в отношении применения лекарственных препаратов при вновь возникающих инфекционных заболеваниях. Однако слабая координация и отсутствие национальных целей и платформ мониторинга и оценки снизили эффективность соответствующих национальных мероприятий. Подход С учетом местных данных и при активном участии соответствующих заинтересованных сторон в Таиланде был разработан первый национальный стратегический план по решению проблемы с устойчивостью возбудителей к противомикробным препаратам. Местные условия До разработки плана неэффективная координация означала, что профили устойчивости возбудителей к противомикробным препаратам, составленные в дозорных больницах, неэффективно использовались при принятии клинических решений. Отсутствовала единая система для наблюдения за устойчивостью возбудителей к противомикробным препаратам, а также система мониторинга применения противомикробных препаратов у людей, сельскохозяйственных и домашних животных, и информированность общественности об устойчивости возбудителей к противомикробным препаратам была недостаточной.
Ос ущес тв ленные перемены В а в г у с те 2 0 1 6 го д а Правительство Таиланда одобрило национальный стратегический план по решению проблемы устойчивости возбудителей к противомикробным препаратам, который включал шесть стратегических мероприятий и пять целей. Национальный управляющий комитет руководит реализацией плана, и в двухгодичный обзор общественного здравоохранения включен встроенный модуль оценки распространенности использования антибиотиков в домашних условиях и осведомленности общественности о микробной устойчивости. Также была введена национальная система наблюдения за применением антимикробных препаратов. Выводы Для эффективной реализации национального плана крайне важны решительная политическая приверженность, национальная ответственность и наличие соответствующего многосекторального институционального потенциала. Надежная платформа мониторинга и оценки в настоящее время вносит свой вклад в научно обоснованные вмешательства. Комплексную систему надзора за устойчивостью возбудителей к противомикробным препаратам все еще предстоит создать.
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Resumen
Resistencia a los antimicrobianos: de un programa mundial a un plan estratégico nacional, Tailandia Situación En Tailandia, la resistencia a los antimicrobianos ha formado un pequeño componente de las políticas y estrategias de medicamentos nacionales sobre las enfermedades infecciosas emergentes. No obstante, la escasa coordinación y la ausencia de objetivos nacionales y plataformas de control y evaluación han reducido la efectividad de las medidas nacionales correspondientes. Enfoque Sobre la base de las pruebas locales y con la gran participación de partes interesadas relevantes, se ha desarrollado en Tailandia el primer plan estratégico nacional sobre la resistencia a los antimicrobianos. Marco regional Antes de desarrollar el plan, la mala coordinación provocó que los perfiles de resistencia a los antimicrobianos producidos en los hospitales centinela no se utilizasen de forma adecuada para la toma de decisiones clínicas. No existía un sistema integrado para la vigilancia de la resistencia a los antimicrobianos, ni un sistema para el control del consumo de medicamentos antimicrobianos por parte de humanos, ganado y mascotas, ni apenas concienciación pública sobre la resistencia a los antimicrobianos.
Cambios importantes En agosto de 2016, el gobierno tailandés aprobó un plan estratégico nacional sobre la resistencia a los antimicrobianos que estaba formado por seis medidas estratégicas y cinco objetivos. Un comité directivo nacional dirige la implementación del plan y un módulo para evaluar la prevalencia del uso doméstico de antibióticos y se ha integrado la concienciación sobre la resistencia a los antimicrobianos en la encuesta nacional bienal sobre salud. También se ha iniciado un sistema nacional para la vigilancia del consumo de antimicrobianos. Lecciones aprendidas Un fuerte compromiso político, una propiedad nacional y las capacidades institucionales multisectoriales adecuadas serán esenciales para la implementación eficaz del plan nacional. Ahora, una sólida plataforma de control y evaluación contribuye a las intervenciones basadas en pruebas. Sin embargo, aún debe establecerse un sistema integrado para la vigilancia de la resistencia a los antimicrobianos.
